Schedule 13G ownership disclosure

Sagimet Biosciences Inc

Series A Common Stock, par value $0.0001 per share · CUSIP: 786700104

Event date: 2025-06-30

Filing-level shares
2,552,536.00
Percent of class
8.3%
  • Woodline Partners LP

    Shares: 2,552,536.00 · Class: 8.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003593
Form type
SCHEDULE 13G
Filer
Sagimet Biosciences Inc.
CIK
CIK 1400118
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub